Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
21.32
-0.05 (-0.23%)
At close: Nov 11, 2026, 4:00 PM EST
21.41
+0.09 (0.42%)
Pre-market: Nov 12, 2026, 8:08 AM EST
Bausch + Lomb Revenue
In the year 2025, Bausch + Lomb had annual revenue of $5.10B with 6.47% growth. Bausch + Lomb had revenue of $1.38B in the quarter ending September 30, 2026, with 7.34% growth. That makes Bausch + Lomb the 2,478th largest company in the world by revenue and 719th in the United States.
Revenue (ttm)
$5.10B
Revenue Growth
+6.47%
P/S Ratio
1.41
Revenue / Employee
$416,769
Employees
13,000
Market Cap
7.62B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Bausch + Lomb breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.10B | 310.00M | 6.47% |
| Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
| Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
| Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
| Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
| Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
| Dec 31, 2019 | 3.78B | 113.00M | 3.08% |
| Dec 31, 2018 | 3.67B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.61B |
| Avantor | 6.64B |
| The Cooper Companies | 4.24B |
| Align Technology | 4.16B |
| AptarGroup | 3.99B |
| MiniMed Group | 3.22B |
| Teleflex | 2.26B |
| ICU Medical | 2.18B |
BLCO News
- 10 days ago - Bausch + Lomb downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 13 days ago - Bausch + Lomb price target raised to $20 from $16 at Deutsche Bank - TheFly
- 14 days ago - Bausch + Lomb price target raised to $22 from $16 at JPMorgan - TheFly
- 14 days ago - Bausch + Lomb announces publication of results from survey on dry eye symptoms - TheFly
- 14 days ago - Bausch + Lomb price target raised to $23 from $21 at Citi - TheFly
- 14 days ago - Bausch + Lomb Announces Publication of Multinational Survey Results Highlighting the Burden of Dry Eye Symptoms and Opportunities for Improved Awareness and Patient Education - Business Wire
- 15 days ago - Bausch + Lomb Earnings Call Transcript: Q3 2026 - Transcripts
- 15 days ago - Bausch + Lomb Slides: Q3 2026 - Filings